1. Verweij SP, Lanjouw E, Bax CJ, Quint KD, Oostvogel PM, Dörr J, Pleijster J, de Vries HJC, Peters RPH, Ouburg SMorré SA.
    Serovar D and E of serogroup B induce highest serological responses in urogenital Chlamydia trachomatis infections.
    BMC Infect. Dis.2014;14:3. | doi:10.1186/1471-2334-14-3
  2. Peña AS.
    Immunogenetics of non celiac gluten sensitivity.
    Gastroenterol Hepatol Bed Bench 2014;7(1):1-5.
  3. Lal JA, Morré SA, Brand A.
    The overarching framework of translation and integration in healthcare: a case for the LAL model.
    Personalized Medicine 2014;11(1),41-62. | doi: 10.2217/pme.13.97
  4. van Aar F, de Moraes M,  Morré SA, van Bergen JEAM, van der Klis F, Land J, van der Sande MAB, van den Broek IVF.
    Chlamydia trachomatis IgG seroprevalence in the general population of the Netherlands in 1996 and in 2007: differential changes by gender and age.
    Sex Transm Infect. 2014;90(5):434-40 | doi:10.1136/sextrans-2013-051074
  5. Al-Kuhlani M, Rothchild J, Pal S, de la Maza L, Ouburg SMorré SA, Dean D, Ojcius DM.
    TRAIL-R1 is a negative regulator of pro-inflammatory responses and modulates long-term sequelae resulting from Chlamydia trachomatis infections in humans.
    PLoS ONE 2014;9(4): e93939. | doi:10.1371/journal.pone.0093939
  6. van den Broek IVF, Land JA, van Bergen JEAM, Morré SA, van der Sande MAB.
    Chlamydia trachomatis antibody testing in vaginal mucosal material versus blood samples of women attending a fertility clinic and an STI clinic.
    Obstet Gynecol Int 2014, Article ID 601932, 9 pages. | doi:10.1155/2014/601932
  7. Broers CJM, Gemke RJBJ, Morré SA, Weijerman ME, van Furth AM.
    Increased production of interleukin-10 in children with Down syndrome upon ex vivo stimulation with Streptococcus pneumoniae.
    Pediatr Res 2014;75(1-1):109-13. | doi:10.1038/pr.2013.173.
  8. Verweij SP, Quint KD, Bax CJ, van Leeuwen AP, Mutsaers JAEM, Jansen CL, Oostvogel PM, Ouburg S, Morré SA, Peters RPH.
    Serogroup distribution of urogenital Chlamydia trachomatis in urban ethnic groups in The Netherlands.
    Epidemiology and Infection 2014;142(02):409-14 | doi: 10.1017/S095026881300071X
  9. Heiligenberg M, Verweij SP, Speksnijder AGCL, Morré SA, de Vries HJC, Schim van der Loeff MF.
    No evidence for LGV transmission among heterosexuals in Amsterdam, the Netherlands.
    BMC Res Notes. 2014;7(1):355. | doi:10.1186/1756-0500-7-355
  10. Branković I, Malogajski J, Morré SA.
    Biobanking and translation of human genetics and genomics for infectious diseases.
    Applied & Translational Genomics 2014;3:30–35. | doi:10.1016/j.atg.2014.04.001
  11. Pereboom MTR, Spelten ER, Manniën J, Rours GIJG, Morré SA, Schellevis FG, Hutton EK.
    Knowledge and acceptability of Chlamydia trachomatis screening among pregnant women and their partners; a cross-sectional study.
    BMC Public Health 2014;14:704 | doi:10.1186/1471-2458-14-704
  12. de Viron S, Morré SA, van Oyen H, Brand A, Ouburg S.
    Genetic similarities between comorbidities of tobacco use disorders and related comorbidities: an exploratory study.
    BMC Med Genet 2014;15:85 | doi:10.1186/1471-2350-15-85
  13. Peters RPH, Dubbink JH, van der Eem L, Verweij SP, Bos MLA, Ouburg S, Lewis DA, Struthers H, McIntyre JA, Morré SA.
    Cross-sectional study of genital, rectal, and pharyngeal Chlamydia and gonorrhea in women in rural South Africa.
    Sex Transm Dis 2014;41(9):564-9 | doi:10.1097/OLQ.0000000000000175
  14. De Puysseleyr K, De Puysseleyr L, Dhondt H, Geens T, Braeckman L, Morré SA, Cox E, Vanrompay D.
    Evaluation of the presence and zoonotic transmission of Chlamydia suis in a pig slaughterhouse.
    BMC Infect Dis. 2014;14:560 | doi:10.1186/s12879-014-0560-x
  15. Asner SA, Morré SA, Bochud PY, Greub G.
    Host factors and genetic susceptibility to infections due to intracellular bacteria and fastidious organisms.
    Clin Microbiol Infect 2014;20(12):1246-53. | doi:10.1111/1469-0691.12806